Previous 10 | Next 10 |
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Chris Linthwaite, President and CEO, and Vikram Jo...
Are you making a list of penny stocks to watch before next week? Today we’re looking at four tech and biotech stocks turning heads in the stock market today. While there are plenty of hot trends to follow right now, things like the metaverse, DeFi, and, yes, even biotechnology are in...
Streamlines Operations to Reduce Hands-On Time, Accelerate Results Broad Menu of Applications with Automated Workflow Providing Sample-to-Answer Solutions on a Single Platform SOUTH SAN FRANCISCO, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASD...
The following slide deck was published by Fluidigm Corporation in conjunction with their 2021 Q3 earnings call. For further details see: Fluidigm Corporation 2021 Q3 - Results - Earnings Call Presentation
Fluidigm Corporation (FLDM) Q3 Earnings Conference Call November 9, 2021, 04:30 PM ET Company Participants Chris Linthwaite – CEO Peter Denardo – IR Vikram Jog – CFO Conference Call Participants Presentation Operator Good afternoon and thank you for standing by. Welcome t...
Fluidigm (NASDAQ:FLDM): Q3 GAAP EPS of -$0.18 beats by $0.04. Revenue of $28.5M (-28.5% Y/Y) misses by $1.5M. Shares -1.45%. Press Release For further details see: Fluidigm EPS beats by $0.04, misses on revenue
Board Undertaking Review of Range of Value-Enhancing Opportunities SOUTH SAN FRANCISCO, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today...
SOUTH SAN FRANCISCO, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Imaging Mass Cytometry™ (IMC™) is being utiliz...
SOUTH SAN FRANCISCO, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will report third quarter 2021 financial result...
SOUTH SAN FRANCISCO, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the agenda for its IMC™ Summit: Uncovering Spatial Biology...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report second quarter 2024 financial results on Wednesday, July 31, 2024, after the close of the...
SOUTH SAN FRANCISCO, Calif and SALT LAKE CITY, May 28, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that it has purchased the LSA XT system from Carterra ® , a leading provider of high-throughput large and small molecule screening and characteriza...
Ahead of plan on operating expense synergies; $50 million of $80 million target to be achieved by year-end 2024 with remaining balance in FY2025 Delivered pro forma combined revenue of $46.2 million, gross margin of 49.2%, non-GAAP gross margin of 56.3%, operating expense reduction of app...